Related references
Note: Only part of the references are listed.Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Giuseppe Lo Russo et al.
CLINICAL CANCER RESEARCH (2019)
Induction of innate immune memory: the role of cellular metabolism
Jorge Dominguez-Andres et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Targeting myeloid cells in the tumor sustaining microenvironment
Jonathan Schupp et al.
CELLULAR IMMUNOLOGY (2019)
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)
Renate Schreiber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
Drug development in the era of precision medicine
Sarah A. Dugger et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Defining Impaired Respiratory Health A Paradigm Shift for Pulmonary Medicine
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Convergence of Cancer Metabolism and Immunity: an Overview
Chi Van Dang et al.
BIOMOLECULES & THERAPEUTICS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Romana T. Netea-Maier et al.
CANCER LETTERS (2018)
Circuit Design Features of a Stable Two-Cell System
Xu Zhou et al.
CELL (2018)
Metabolic Induction of Trained Immunity through the Mevalonate Pathway
Siroon Bekkering et al.
CELL (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Low-Protein Diet Induces IRE1 alpha-Dependent Anticancer Immunosurveillance
Camila Rubio-Patino et al.
CELL METABOLISM (2018)
The interstitial macrophage: A long-neglected piece in the puzzle of lung immunity
Maude Liegeois et al.
CELLULAR IMMUNOLOGY (2018)
C-MET inhibitors for advanced non-small cell lung cancer
Giulia Pasquini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
David Linehan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Regulation of macrophage immunometabolism in atherosclerosis
Graeme J. Koelwyn et al.
NATURE IMMUNOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Canakinumab and Lung Cancer: Intriguing, but Is It Real?
Bruce A. Chabner et al.
ONCOLOGIST (2018)
Lung Interstitial Macrophages: Past, Present, and Future
Joey Schyns et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Targeting Macrophages in Cancer: From Bench to Bedside
Ashleigh R. Poh et al.
FRONTIERS IN ONCOLOGY (2018)
Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
Ralph L. Millett et al.
ANTICANCER RESEARCH (2018)
New-generation glucose transporter inhibitors targeting non-small cell lung cancer and triple-negative breast cancer
Pratik Shriwas et al.
CANCER RESEARCH (2018)
Diverse Functions of Macrophages in Different Tumor Microenvironments
Ming Yang et al.
CANCER RESEARCH (2018)
Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers
Michael P. Murphy et al.
CELL (2018)
Targeting macrophages for cancer therapy disrupts bone homeostasis and impairs bone marrow erythropoiesis in mice bearing Lewis lung carcinoma tumors
Weiqiang Jing et al.
CELLULAR IMMUNOLOGY (2018)
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Jonathan M. Weiss et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Macrophages of distinct origins contribute to tumor development in the lung
Pierre-Louis Loyher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer
Ismini Lasithiotaki et al.
PLOS ONE (2018)
Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
Shuhei Suzuki et al.
Oncotarget (2018)
Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
David Crossman et al.
JOURNAL OF THORACIC DISEASE (2018)
Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity
Gianluca D'Agostino et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
Katharina Helene Susek et al.
FRONTIERS IN IMMUNOLOGY (2018)
CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
Ori Wald
JOURNAL OF CLINICAL MEDICINE (2018)
Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity
Yushi Yao et al.
CELL (2018)
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Aldo Pezzuto et al.
CURRENT MOLECULAR MEDICINE (2018)
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017
Rafael Lozano et al.
LANCET (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
William Bradley Coley, MD, and the phenomenon of spontaneous regression
Leonard F. Vernon
IMMUNOTARGETS AND THERAPY (2018)
Why do BCL-2 inhibitors work and where should we use them in the clinic?
Joan Montero et al.
CELL DEATH AND DIFFERENTIATION (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy
Ashley Orillion et al.
CLINICAL CANCER RESEARCH (2018)
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
Weiran Liu et al.
ONCOTARGET (2017)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
Reshma Rani et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Exposure to Bacterial CpG DNA Protects from Airway Allergic Inflammation by Expanding Regulatory Lung Interstitial Macrophages
Catherine Sabatel et al.
IMMUNITY (2017)
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
Yu Zhu et al.
IMMUNITY (2017)
The Cytokine TGF-β Promotes the Development and Homeostasis of Alveolar Macrophages
Xueyang Yu et al.
IMMUNITY (2017)
Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression
Huifang Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Alexander V. Misharin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension
Steven C. Pugliese et al.
JOURNAL OF IMMUNOLOGY (2017)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Matthew D. Hellmann et al.
LANCET ONCOLOGY (2017)
Inflammasomes in the lung
James W. Pinkerton et al.
MOLECULAR IMMUNOLOGY (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states
David Furman et al.
NATURE MEDICINE (2017)
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
T. S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metabolic origins of spatial organization in the tumor microenvironment
Carlos Carmona-Fontaine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Nan Guo Ring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Sean P. Arlauckas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
Chi-Fu Chiang et al.
ONCOTARGET (2017)
Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
Oakley C. Olson et al.
CELL REPORTS (2017)
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
Xiuli Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Promoter specificity and efficacy in Conditional and Inducible Transgenic targeting of Lung Macrophages
Alexandra L. McCubbrey et al.
FRONTIERS IN IMMUNOLOGY (2017)
Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition
Wenzhe Song et al.
FRONTIERS IN IMMUNOLOGY (2017)
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu et al.
FRONTIERS IN IMMUNOLOGY (2017)
ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
Eun Young Kim et al.
NEOPLASIA (2017)
Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation
Fawaz Awad et al.
PLOS ONE (2017)
Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease
Emiel F. M. Wouters
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Roderik M. Kortlever et al.
CELL (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Bone: A Fertile Soil for Cancer Metastasis
Thomas R. Coughlin et al.
CURRENT DRUG TARGETS (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Tomasz Prochnicki et al.
CELL METABOLISM (2017)
Three Unique Interstitial Macrophages in the Murine Lung at Steady State
Sophie L. Gibbings et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin et al.
CELL (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Lipid metabolism and lung cancer
Maria Merino Salvador et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages
Liwei Sun et al.
CELLULAR IMMUNOLOGY (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Immunometabolism governs dendritic cell and macrophage function
Luke A. J. O'Neill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Macrophages, Inflammation, and Lung Cancer
Emma M. Conway et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
How One Thing Led to Another
Irving Weissman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
The Multifaceted Role of Perivascular Macrophages in Tumors
Claire E. Lewis et al.
CANCER CELL (2016)
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Shohei Koyama et al.
CANCER RESEARCH (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
Vicky Lampropoulou et al.
CELL METABOLISM (2016)
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
Holger Siebeneicher et al.
CHEMMEDCHEM (2016)
Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
Yanyan Lou et al.
CLINICAL CANCER RESEARCH (2016)
Developmental origin of lung macrophage diversity
Serena Y. S. Tan et al.
DEVELOPMENT (2016)
Tissue-Resident Macrophage Ontogeny and Homeostasis
Florent Ginhoux et al.
IMMUNITY (2016)
Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer
Joanna M. Poczobutt et al.
JOURNAL OF IMMUNOLOGY (2016)
CD169+ macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer
Andy C. Wu et al.
JOURNAL OF PATHOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Molecular control of activation and priming in macrophages
Christopher K. Glass et al.
NATURE IMMUNOLOGY (2016)
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Robert U. Svensson et al.
NATURE MEDICINE (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
The modern interleukin-1 superfamily: Divergent roles in obesity
Man K. S. Lee et al.
SEMINARS IN IMMUNOLOGY (2016)
Integrating immunometabolism and macrophage diversity
Maxim N. Artyomov et al.
SEMINARS IN IMMUNOLOGY (2016)
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
Robin E. Frink et al.
ONCOTARGET (2016)
VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
Marlous Arjaans et al.
ONCOTARGET (2016)
Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis
Pin Wu et al.
ONCOTARGET (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
Ryuichiro Arakaki et al.
CANCER MEDICINE (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
Hui Zhao et al.
SCIENTIFIC REPORTS (2016)
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
Beichu Guo et al.
SCIENTIFIC REPORTS (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The Non-Small Cell Lung Cancer Immune Contexture A Major Determinant of Tumor Characteristics and Patient Outcome
Romain Remark et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
A Broken Krebs Cycle in Macrophages
Luke A. J. O'Neill
IMMUNITY (2015)
Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells
Jianpeng Sheng et al.
IMMUNITY (2015)
Mitochondria in the Regulation of Innate and Adaptive Immunity
Samuel E. Weinberg et al.
IMMUNITY (2015)
NLRP3 at the interface of metabolism and inflammation
Moritz Haneklaus et al.
IMMUNOLOGICAL REVIEWS (2015)
Emerging concepts in bioenergetics and cancer research: Metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy
Emilie Obre et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B
William R. Wikoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis
Bin-Zhi Qian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
Sharad K. Sharma et al.
JOURNAL OF IMMUNOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer
Jun Osugi et al.
LUNG CANCER (2015)
The development and function of lung-resident macrophages and dendritic cells
Manfred Kopf et al.
NATURE IMMUNOLOGY (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Patrolling monocytes control tumor metastasis to the lung
Richard N. Hanna et al.
SCIENCE (2015)
Differential expression of inflammasomes in lung cancer cell lines and tissues
Hui Kong et al.
TUMOR BIOLOGY (2015)
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
Allison S. Harney et al.
CANCER DISCOVERY (2015)
Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
Ling Ding et al.
ONCOTARGET (2015)
Immune surveillance of the lung by migrating tissue monocytes
Mathieu P. Rodero et al.
ELIFE (2015)
Chronic obstructive pulmonary disease
Peter J. Barnes et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
A. A. Chiappori et al.
ANNALS OF ONCOLOGY (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Irene Brana et al.
TARGETED ONCOLOGY (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The immune system, bone and RANKL
Matteo M. Guerrini et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
J-Y Douillard et al.
BRITISH JOURNAL OF CANCER (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Lung Nodule and Functional Changes in Smokers After Smoking Cessation Short-Term Treatment
Eliana Maci et al.
CANCER INVESTIGATION (2014)
Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers
Aaron N. Hata et al.
CANCER RESEARCH (2014)
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Yonit Lavin et al.
CELL (2014)
Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities
David Gosselin et al.
CELL (2014)
Mechanisms and Functions of Inflammasomes
Mohamed Lamkanfi et al.
CELL (2014)
Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
Han Xie et al.
CELL METABOLISM (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Understanding macrophage diversity at the ontogenic and transcriptomic levels
Emmanuel L. Gautier et al.
IMMUNOLOGICAL REVIEWS (2014)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity
Kristin Westphalen et al.
NATURE (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages
Christoph Schneider et al.
NATURE IMMUNOLOGY (2014)
A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer
D. Luis-Ravelo et al.
ONCOGENE (2014)
Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study
Pingping Hu et al.
PLOS ONE (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Alveolar macrophages: plasticity in a tissue-specific context
Tracy Hussell et al.
NATURE REVIEWS IMMUNOLOGY (2014)
MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein
Po-Lin Kuo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta et al.
CANCER BIOLOGY & THERAPY (2013)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
New molecular insights in tobacco-induced lung cancer
Giuseppe Tonini et al.
FUTURE ONCOLOGY (2013)
Angiotensin II Drives the Production of Tumor-Promoting Macrophages
Virna Cortez-Retamozo et al.
IMMUNITY (2013)
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Simon Yona et al.
IMMUNITY (2013)
Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes
Daigo Hashimoto et al.
IMMUNITY (2013)
Lactate Dehydrogenase A in Cancer: A Promising Target for Diagnosis and Therapy
Ping Miao et al.
IUBMB LIFE (2013)
Acidosis Drives Damage-associated Molecular Pattern (DAMP)-induced Interleukin-1 Secretion via a Caspase-1-independent Pathway
Michelle E. Edye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Pro-Surfactant Protein B As a Biomarker for Lung Cancer Prediction
Don D. Sin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
Martin Guilliams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome
Andreas Carus et al.
LUNG CANCER (2013)
Myeloid hypoxia-inducible factor 1α prevents airway allergy in mice through macrophage-mediated immunoregulation
M. Toussaint et al.
MUCOSAL IMMUNOLOGY (2013)
Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections
M. Guilliams et al.
MUCOSAL IMMUNOLOGY (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Small nanobody drugs win big backing from pharma
Sarah C. P. Williams
NATURE MEDICINE (2013)
Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer
Jian Zhang et al.
MEDICAL ONCOLOGY (2013)
Impact of GLUT1 and Ki-67 expression on early-stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification
Yuho Maki et al.
ONCOLOGY REPORTS (2013)
Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment
Joanna M. Poczobutt et al.
PLOS ONE (2013)
Emergence of spatial structure in the tumor microenvironment due to the Warburg effect
Carlos Carmona-Fontaine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of c-MYC in tumor-associated macrophages and cancer progression
Oscar M. Pello et al.
ONCOIMMUNOLOGY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Activated CD69+ T Cells Foster Immune Privilege by Regulating IDO Expression in Tumor-Associated Macrophages
Qiyi Zhao et al.
JOURNAL OF IMMUNOLOGY (2012)
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice
Susanna Choi et al.
JOURNAL OF IMMUNOLOGY (2012)
Systemic Analysis of PPARγ in Mouse Macrophage Populations Reveals Marked Diversity in Expression with Critical Roles in Resolution of Inflammation and Airway Immunity
Emmanuel L. Gautier et al.
JOURNAL OF IMMUNOLOGY (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer
Naohiro Kobayashi et al.
LUNG CANCER (2012)
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel et al.
NATURE IMMUNOLOGY (2012)
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
Emmanuel L. Gautier et al.
NATURE IMMUNOLOGY (2012)
Origins of tumor-associated macrophages and neutrophils
Virna Cortez-Retamozo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Christian Schulz et al.
SCIENCE (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Surgery for skeletal metastases in lung cancer
Rudiger J. Weiss et al.
ACTA ORTHOPAEDICA (2011)
Macrophages and Tissue Injury: Agents of Defense or Destruction?
Debra L. Laskin et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models
Ayumu Taguchi et al.
CANCER CELL (2011)
Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
Qing Chen et al.
CANCER CELL (2011)
Metabolic Connections during Apoptotic Cell Engulfment
Claudia Z. Han et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in
Armin Ehninger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Suman K. Das et al.
SCIENCE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
The calcified lung nodule: What does it mean
Ali Nawaz Khan et al.
ANNALS OF THORACIC MEDICINE (2010)
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs
Ingrid G. Winkler et al.
BLOOD (2010)
Why not treat human cancer with interleukin-1 blockade?
Charles A. Dinarello
CANCER AND METASTASIS REVIEWS (2010)
Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions
Seth B. Coffelt et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Hongxia Z. Imtiyaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism
Anna D. Baker et al.
JOURNAL OF LIPID RESEARCH (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer
I. Hernandez et al.
ONCOGENE (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
How the Noninflammasome NLRs Function in the Innate Immune System
Jenny P. Y. Ting et al.
SCIENCE (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Macrophage death and defective inflammation resolution in atherosclerosis
Ira Tabas
NATURE REVIEWS IMMUNOLOGY (2010)
Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model
Seyed Javad Moghaddam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood resident monocytes, and embryonic macrophages suggests common functions and developmental relationships
Ferdinando Pucci et al.
BLOOD (2009)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
Khaled M. Sarraf et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Binzhi Qian et al.
PLOS ONE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
The Nalp3 inflammasome is essential for the development of silicosis
Suzanne L. Cassel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica
Catherine Dostert et al.
SCIENCE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications
Michele De Palma et al.
TRENDS IN IMMUNOLOGY (2007)
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
Zhenhua Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
Anne M. Lewis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Acute effect of cigarette smoke on TNF-α release by macrophages mediated through the erk1/2 pathway
Loutfig Demirjian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Alveolar macrophage function is altered in patients with lung cancer
DS Pouniotis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Ron N. Apte et al.
CANCER AND METASTASIS REVIEWS (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1β-induced neovascularization and tumor growth
S Nakao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases
RJ Phillips et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors:: In vivo analysis of tumor-stromal interaction
Y Saijo et al.
JOURNAL OF IMMUNOLOGY (2002)
Acute cigarette smoke exposure induces apoptosis of alveolar macrophages
K Aoshiba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
M-1/M-2 macrophages and the Th1/Th2 paradigm
CD Mills et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
